CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale President & CEO sold 91,714 shares at an average $19.26 ($1,766,081)
- 4 Open-market sale SVP & Chief Operating Officer sold 3,177 shares at $19.32 ($61,380)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,177 shares at $19.32 ($61,380)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,956 shares at $19.32 ($57,110)
- 4 Open-market sale SVP & Chief Medical Officer sold 1,997 shares at $19.32 ($38,582)
- 4 Open-market sale SVP & Chief Scientific Officer sold 1,701 shares at $19.32 ($32,863)
- 4 Open-market buy Director bought 35,000 shares at $17.95 ($628,250)
- 4 Open-market sale SVP & Chief Medical Officer sold 54,920 shares at $21.10 ($1,158,812)
- 4 Open-market sale Director sold 30,000 shares at $20.76 ($622,800)
- 4 Open-market sale SVP & Chief Medical Officer sold 45,080 shares at an average $21.08 ($950,318)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market sale SVP & Chief Operating Officer sold 101,700 shares at $19.24 ($1,956,708)
- 4 Open-market sale SVP & Chief Accounting Officer sold 2,651 shares at $19.55 ($51,827)
- 4 Open-market sale President & CEO sold 8,388 shares at $19.55 ($163,985)
- 4 Open-market sale SVP & Chief Operating Officer sold 3,146 shares at $19.55 ($61,504)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,179 shares at $19.55 ($62,149)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,959 shares at $19.55 ($57,848)
- 4 Open-market sale SVP & Chief Medical Officer sold 1,450 shares at $19.55 ($28,348)
- 4 Open-market sale SVP & Chief Scientific Officer sold 1,701 shares at $19.55 ($33,255)
- 4 Open-market sale Director sold 5,000 shares at $19.79 ($98,950)
Page 21 of 49 · 970 filings